Stock RADLY RAIA DROGASIL S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Raia Drogasil S.A. OTC Markets

Equities

RADLY

US7507231089

Market Closed - OTC Markets
Other stock markets
 10:07:09 2024-07-01 EDT 		5-day change 1st Jan Change
4.31 USD -5.27% Intraday chart for Raia Drogasil S.A. +3.86% -40.14%
05-08 Transcript : Raia Drogasil S.A., Q1 2024 Earnings Call, May 08, 2024
05-07 Raia Drogasil S.A. acquired remaining 15% stake in 4Bio Medicamentos S.A. CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

  • Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 51% by 2026.
  • The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
  • Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses

  • The company does not generate enough profits, which is an alarming weak point.
  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 33.11 times its estimated earnings per share for the ongoing year.
  • In relation to the value of its tangible assets, the company's valuation appears relatively high.
  • The valuation of the company is particularly high given the cash flows generated by its activity.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.

Ratings chart - Surperformance

Sector: Drug Retailers

1st Jan change Capi. Investor Rating ESG Refinitiv
RAIA DROGASIL S.A. Stock Raia Drogasil S.A.
-40.14% 7.87B -
AIN HOLDINGS INC. Stock Ain Holdings Inc.
+35.72% 1.29B -
QOL HOLDINGS CO., LTD. Stock Qol Holdings Co., Ltd.
-8.21% 347M -
NIHON CHOUZAI CO.,LTD. Stock NIHON CHOUZAI Co.,Ltd.
+7.01% 277M -
SALUS, LJUBLJANA, D. D. Stock SALUS, Ljubljana, d. d.
+8.89% 221M - -
PETMED EXPRESS, INC. Stock PetMed Express, Inc.
-46.83% 80.41M
C
GREEN CROSS HEALTH LIMITED Stock Green Cross Health Limited
-32.11% 64.49M - -
MEDICAL IKKOU GROUP CO.,LTD. Stock Medical Ikkou Group Co.,Ltd.
+28.45% 61.22M - -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. RADL3 Stock
  4. RADLY Stock
  5. Ratings Raia Drogasil S.A.